Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Nov 22;83(11):1473–1479. doi: 10.1054/bjoc.2000.1488

Expression of calcium-binding protein S100A2 in breast lesions

D Liu 1, P S Rudland 1, D R Sibson 2, A Platt-Higgins 1, R Barraclough 1
PMCID: PMC2363420  PMID: 11076656

Abstract

A suppression subtraction cDNA library representing mRNAs expressed at a higher level in a benign breast tumour-derived cell line relative to the malignant MCF-7A cell line contained cDNAs corresponding to mRNAs for plasminogen activator inhibitor I, annexin VIII and the EF-hand protein S100A2. S100A2 protein has previously been shown to be expressed in normal human breast epithelium, but not in human breast carcinoma cell lines. Using a PCR-based assay and in situ hybridization on histological sections of human breast specimens, the mRNA for S100A2 was shown to be present in all benign breast lesions examined as well as in normal epithelium. S100A2 mRNA was detectable in 37% of specimens of carcinoma in situ, but in less than 15% of carcinoma specimens. The results suggest that the loss of S100A2 is associated with the development of malignant cells and is not associated with early tumour development. © 2000 Cancer Research Campaign http://www.bjcancer.com

Keywords: S100A2, breast cancer, in situ hybridization, carcinoma in situ, suppression subtractive hybridization

Full Text

The Full Text of this article is available as a PDF (349.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. Basic local alignment search tool. J Mol Biol. 1990 Oct 5;215(3):403–410. doi: 10.1016/S0022-2836(05)80360-2. [DOI] [PubMed] [Google Scholar]
  2. Ambartsumian N. S., Grigorian M. S., Larsen I. F., Karlstrøm O., Sidenius N., Rygaard J., Georgiev G., Lukanidin E. Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene. Oncogene. 1996 Oct 17;13(8):1621–1630. [PubMed] [Google Scholar]
  3. Anandappa S. Y., Winstanley J. H., Leinster S., Green B., Rudland P. S., Barraclough R. Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease. Br J Cancer. 1994 Apr;69(4):772–776. doi: 10.1038/bjc.1994.146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barraclough R., Kimbell R., Rudland P. S. Differential control of mRNA levels for Thy-1 antigen and laminin in rat mammary epithelial and myoepithelial-like cells. J Cell Physiol. 1987 Jun;131(3):393–401. doi: 10.1002/jcp.1041310311. [DOI] [PubMed] [Google Scholar]
  5. Briand P., Petersen O. W., Van Deurs B. A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium. In Vitro Cell Dev Biol. 1987 Mar;23(3):181–188. doi: 10.1007/BF02623578. [DOI] [PubMed] [Google Scholar]
  6. Brockdorff N., Ashworth A., Kay G. F., McCabe V. M., Norris D. P., Cooper P. J., Swift S., Rastan S. The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus. Cell. 1992 Oct 30;71(3):515–526. doi: 10.1016/0092-8674(92)90519-i. [DOI] [PubMed] [Google Scholar]
  7. Chang K. S., Wang G., Freireich E. J., Daly M., Naylor S. L., Trujillo J. M., Stass S. A. Specific expression of the annexin VIII gene in acute promyelocytic leukemia. Blood. 1992 Apr 1;79(7):1802–1810. [PubMed] [Google Scholar]
  8. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  9. Davies B. R., Davies M. P., Gibbs F. E., Barraclough R., Rudland P. S. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene. 1993 Apr;8(4):999–1008. [PubMed] [Google Scholar]
  10. Davies M. P., Rudland P. S., Robertson L., Parry E. W., Jolicoeur P., Barraclough R. Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. Oncogene. 1996 Oct 17;13(8):1631–1637. [PubMed] [Google Scholar]
  11. Diatchenko L., Lau Y. F., Campbell A. P., Chenchik A., Moqadam F., Huang B., Lukyanov S., Lukyanov K., Gurskaya N., Sverdlov E. D. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6025–6030. doi: 10.1073/pnas.93.12.6025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta. 1999 Jul 8;1450(3):191–231. doi: 10.1016/s0167-4889(99)00058-0. [DOI] [PubMed] [Google Scholar]
  13. Engel L. W., Young N. A. Human breast carcinoma cells in continuous culture: a review. Cancer Res. 1978 Nov;38(11 Pt 2):4327–4339. [PubMed] [Google Scholar]
  14. Feinberg A. P., Vogelstein B. "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. Anal Biochem. 1984 Feb;137(1):266–267. doi: 10.1016/0003-2697(84)90381-6. [DOI] [PubMed] [Google Scholar]
  15. Guru S. C., Agarwal S. K., Manickam P., Olufemi S. E., Crabtree J. S., Weisemann J. M., Kester M. B., Kim Y. S., Wang Y., Emmert-Buck M. R. A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus. Genome Res. 1997 Jul;7(7):725–735. doi: 10.1101/gr.7.7.725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Han J. H., Stratowa C., Rutter W. J. Isolation of full-length putative rat lysophospholipase cDNA using improved methods for mRNA isolation and cDNA cloning. Biochemistry. 1987 Mar 24;26(6):1617–1625. doi: 10.1021/bi00380a020. [DOI] [PubMed] [Google Scholar]
  17. Ke Y., Fernig D. G., Wilkinson M. C., Winstanley J. H., Smith J. A., Rudland P. S., Barraclough R. The expression of basic fibroblast growth factor and its receptor in cell lines derived from normal human mammary gland and a benign mammary lesion. J Cell Sci. 1993 Sep;106(Pt 1):135–143. doi: 10.1242/jcs.106.1.135. [DOI] [PubMed] [Google Scholar]
  18. Laborda J. 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res. 1991 Jul 25;19(14):3998–3998. doi: 10.1093/nar/19.14.3998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lee S. W., Tomasetto C., Swisshelm K., Keyomarsi K., Sager R. Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2504–2508. doi: 10.1073/pnas.89.6.2504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Maelandsmo G. M., Flørenes V. A., Mellingsaeter T., Hovig E., Kerbel R. S., Fodstad O. Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma. Int J Cancer. 1997 Aug 22;74(4):464–469. doi: 10.1002/(sici)1097-0215(19970822)74:4<464::aid-ijc19>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  21. Mandinova A., Atar D., Schäfer B. W., Spiess M., Aebi U., Heizmann C. W. Distinct subcellular localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rises in intracellular calcium. J Cell Sci. 1998 Jul 30;111(Pt 14):2043–2054. doi: 10.1242/jcs.111.14.2043. [DOI] [PubMed] [Google Scholar]
  22. Mueller A., Bächi T., Höchli M., Schäfer B. W., Heizmann C. W. Subcellular distribution of S100 proteins in tumor cells and their relocation in response to calcium activation. Histochem Cell Biol. 1999 Jun;111(6):453–459. doi: 10.1007/s004180050381. [DOI] [PubMed] [Google Scholar]
  23. Pedrocchi M., Schäfer B. W., Mueller H., Eppenberger U., Heizmann C. W. Expression of Ca(2+)-binding proteins of the S100 family in malignant human breast-cancer cell lines and biopsy samples. Int J Cancer. 1994 Jun 1;57(5):684–690. doi: 10.1002/ijc.2910570513. [DOI] [PubMed] [Google Scholar]
  24. Pelicci G., Lanfrancone L., Grignani F., McGlade J., Cavallo F., Forni G., Nicoletti I., Grignani F., Pawson T., Pelicci P. G. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell. 1992 Jul 10;70(1):93–104. doi: 10.1016/0092-8674(92)90536-l. [DOI] [PubMed] [Google Scholar]
  25. Platt-Higgins A. M., Renshaw C. A., West C. R., Winstanley J. H., De Silva Rudland S., Barraclough R., Rudland P. S. Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer. Int J Cancer. 2000 Mar 20;89(2):198–208. [PubMed] [Google Scholar]
  26. Rothe M., Pan M. G., Henzel W. J., Ayres T. M., Goeddel D. V. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell. 1995 Dec 29;83(7):1243–1252. doi: 10.1016/0092-8674(95)90149-3. [DOI] [PubMed] [Google Scholar]
  27. Rudland P. S., Ollerhead G., Barraclough R. Isolation of simian virus 40-transformed human mammary epithelial stem cell lines that can differentiate to myoepithelial-like cells in culture and in vivo. Dev Biol. 1989 Nov;136(1):167–180. doi: 10.1016/0012-1606(89)90139-5. [DOI] [PubMed] [Google Scholar]
  28. Rudland P. S., Platt-Higgins A., Renshaw C., West C. R., Winstanley J. H., Robertson L., Barraclough R. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res. 2000 Mar 15;60(6):1595–1603. [PubMed] [Google Scholar]
  29. Schäfer B. W., Heizmann C. W. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci. 1996 Apr;21(4):134–140. doi: 10.1016/s0968-0004(96)80167-8. [DOI] [PubMed] [Google Scholar]
  30. Tan M., Heizmann C. W., Guan K., Schafer B. W., Sun Y. Transcriptional activation of the human S100A2 promoter by wild-type p53. FEBS Lett. 1999 Feb 26;445(2-3):265–268. doi: 10.1016/s0014-5793(99)00135-0. [DOI] [PubMed] [Google Scholar]
  31. Taylor S. L., Platt-Higgins A., Rudland P. S., Winstanley J. H., Barraclough R. Cytoplasmic staining of c-erbB-2 is not associated with the presence of detectable c-erbB-2 mRNA in breast cancer specimens. Int J Cancer. 1998 May 18;76(4):459–463. doi: 10.1002/(sici)1097-0215(19980518)76:4<459::aid-ijc2>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  32. Wang Y., Rea T., Bian J., Gray S., Sun Y. Identification of the genes responsive to etoposide-induced apoptosis: application of DNA chip technology. FEBS Lett. 1999 Feb 26;445(2-3):269–273. doi: 10.1016/s0014-5793(99)00136-2. [DOI] [PubMed] [Google Scholar]
  33. Watson D. K., McWilliams M. J., Lapis P., Lautenberger J. A., Schweinfest C. W., Papas T. S. Mammalian ets-1 and ets-2 genes encode highly conserved proteins. Proc Natl Acad Sci U S A. 1988 Nov;85(21):7862–7866. doi: 10.1073/pnas.85.21.7862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wicki R., Franz C., Scholl F. A., Heizmann C. W., Schäfer B. W. Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation. Cell Calcium. 1997 Oct;22(4):243–254. doi: 10.1016/s0143-4160(97)90063-4. [DOI] [PubMed] [Google Scholar]
  35. Wun T. C., Kretzmer K. K. cDNA cloning and expression in E. coli of a plasminogen activator inhibitor (PAI) related to a PAI produced by Hep G2 hepatoma cell. FEBS Lett. 1987 Jan 1;210(1):11–16. doi: 10.1016/0014-5793(87)81288-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES